Tuesday, September 1, 2020 at 9:00am to 11:00am
The past few decades have witnessed extraordinary biomedical breakthroughs in treatments for cardiovascular disease, cancer, and infectious diseases like HIV and hepatitis C. But progress against Alzheimer’s disease and related disorders remains frustratingly elusive. This is worrisome because without an effective intervention, dementia prevalence will triple over the next several decades, raising the specter of an aging America with healthy bodies housing deteriorating minds.
Still, there are reasons for optimism, particularly in diagnostics and early treatments – even before cognitive symptoms are present. But when these advances become available, will policymakers be ready with answers on how to value them and have policies in place to support access and prevention? Will novel payment approaches be supported? Will the healthcare system be ready to meet demand?
Join the USC-Brookings Schaeffer Initiative for Health Policy on Sept. 1, 2020, for a conversation on the hopeful signs in clinical development and the policy challenges of how to make Alzheimer’s disease treatments and diagnostics readily available. Register here.